Z-1843-2019 Class III Terminated

Recalled by Cytocell Ltd. — Cambridge, N/A

FDA device recall Z-1843-2019 was initiated by Cytocell Ltd. on Apr 26, 2019 and is designated Class III. Reason for recall: There is an error in the chromomap on the package insert. The recall status is terminated (terminated Jul 16, 2020). Affected quantity: 400.

Recall details

Product Type
Devices
Report Date
Jun 26, 2019
Initiation Date
Apr 26, 2019
Termination Date
Jul 16, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
400

Product description

Aquarius D13S319 Plus Deletion Probe, Model LPH068-A Product Usage: The D13S319 probe, labelled in red, covers a 156kb region including most of the DLEU2 gene, part of the DLEU1 gene and the D13S319 and D13S272 markers. The 13qter subtelomere specific probe, labelled in green, allows identification of chromosome 13 and acts as a control probe.

Reason for recall

There is an error in the chromomap on the package insert.

Distribution pattern

Worldwide Distribution - US Nationwide AL, CO, FL, HI, IA, IL, IN, KY, MA, MD, MI, MO, MS, NC, NJ, NY, TN, TX, UT, WA, and WI. The products were distributed to the following foreign countries: Canada.

Code information

Lot Numbers: 058585, 061111, 061354, 062527

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1843-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1843-2019. Report a data issue: hello@regdatalab.com.